Changeflow GovPing Healthcare FDA Acknowledgment Letter to Whisky A Go Go
Routine Notice Added Final

FDA Acknowledgment Letter to Whisky A Go Go

Email

Summary

The Food and Drug Administration (FDA) has issued an acknowledgment letter to Whisky A Go Go. The letter, originating from the Center for Devices and Radiological Health (CDRH), confirms receipt of correspondence but provides no further details on its content or implications.

What changed

This document is an acknowledgment letter from the FDA's Center for Devices and Radiological Health (CDRH) to Whisky A Go Go, confirming receipt of correspondence. No substantive information regarding the nature of the correspondence, any regulatory actions, or specific requirements is provided in the available content.

As this is merely an acknowledgment, there are no immediate compliance actions required for regulated entities. The document does not impose new obligations, deadlines, or penalties. It serves as a procedural confirmation of receipt by the FDA.

Source document (simplified)

Content

There are no documents available to view or download

Attachments 1

Acknowledgment Letter from FDA DMB to Whisky A Go Go

More Information
- Author(s) CDRH
Download

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2025-V-6768-0002

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Drug Manufacturing Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.